Investigation Overview
Sept. 25, 2012 (Shareholders Foundation) -- An investigation on behalf of investors of Peregrine Pharmaceuticals (NASDAQ:PPHM) shares over potential securities laws violations by Peregrine Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchaser...
You must register (for free) or login to view the entire investigation.